Optimization of Specialty Drug Costs Under the Medical Benefit

To achieve savings, health plans must view a claim payment as an output of the inter-relationships between drug, diagnosis, dosing, unit, and pricing. “Optimization of Specialty Drug Costs Under the Medical Benefit” provides comprehensive details on how a payor can apply modest policy adjustments and some straight-forward network engagement tactics to achieve a 6% to 10% in savings thanks to tighter Medical Drug management controls.

 

Presented by:

Todd Cooperman, PharmD, MBA, RPh
Senior Vice President, Clinical Insight and Analytics
RJ Health

 

Register Below Now: